Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses.
Alibaz-Oner F, Karadeniz A, Ylmaz S, Balkarl A, Kimyon G, Yazc A, Çnar M, Ylmaz S, Yldz F, Bilge ŞY, Bilgin E, Coskun BN, Omma A, Çetin GY, Çağatay Y, Karaaslan Y, Sayarloğlu M, Pehlivan Y, Kalyoncu U, Karadağ Ö, Kaşifoğlu T, Erken E, Pay S, Çefle A, Ksack B, Onat AM, Çobankara V, Direskeneli H. Alibaz-Oner F, et al. Among authors: omma a. Medicine (Baltimore). 2015 Feb;94(6):e494. doi: 10.1097/MD.0000000000000494. Medicine (Baltimore). 2015. PMID: 25674739 Free PMC article.
A single-center rheumatology experience of sarcoidosis: observations from 70 patients.
Konak HE, Güven SC, Atalar E, Akyüz Dağlı P, Koçak Ulucaköy R, Kayacn Erdoğan E, Babaoğlu H, Orhan K, Doğan İ, Maraş Y, Omma A, Küçükşahin O, Erten Ş. Konak HE, et al. Among authors: omma a. Sarcoidosis Vasc Diffuse Lung Dis. 2023 Sep 13;40(3):e2023033. doi: 10.36141/svdld.v40i3.14063. Sarcoidosis Vasc Diffuse Lung Dis. 2023. PMID: 37712373 Free PMC article.
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.
Omma A, Batirel A, Aydin M, Yilmaz Karadag F, Erden A, Kucuksahin O, Armagan B, Güven SC, Karakas O, Gokdemir S, Altunal LN, Buber AA, Gemcioglu E, Zengin O, Inan O, Sahiner ES, Korukluoglu G, Sezer Z, Ozdarendeli A, Kara A, Ates I. Omma A, et al. Hum Vaccin Immunother. 2022 Nov 30;18(6):2122503. doi: 10.1080/21645515.2022.2122503. Epub 2022 Oct 31. Hum Vaccin Immunother. 2022. PMID: 36315843 Free PMC article. Clinical Trial.
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.
Ates I, Batirel A, Aydin M, Karadag FY, Erden A, Kucuksahin O, Armagan B, Guven SC, Karakas O, Gokdemir S, Altunal LN, Buber AA, Gemcioglu E, Zengin O, Inan O, Sahiner ES, Korukluoglu G, Sezer Z, Ozdarendeli A, Omma A, Kara A. Ates I, et al. Among authors: omma a. Vaccines (Basel). 2023 Jul 12;11(7):1234. doi: 10.3390/vaccines11071234. Vaccines (Basel). 2023. PMID: 37515050 Free PMC article.
A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
Pamuk ÖN, Kalyoncu U, Aksu K, Omma A, Pehlivan Y, Çağatay Y, Küçükşahin O, Dönmez S, Çetin GY, Mercan R, Bayındır Ö, Çefle A, Yıldız F, Balkarlı A, Kılıç L, Çakır N, Kısacık B, Öksüz MF, Çobankara V, Onat AM, Sayarlıoğlu M, Öztürk MA, Pamuk GE, Akkoç N. Pamuk ÖN, et al. Among authors: omma a. Rheumatol Int. 2016 Jul;36(7):945-53. doi: 10.1007/s00296-016-3500-9. Epub 2016 May 24. Rheumatol Int. 2016. PMID: 27221456
The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients.
Kalyoncu U, Bayindir Ö, Ferhat Öksüz M, Doğru A, Kimyon G, Tarhan EF, Erden A, Yavuz Ş, Can M, Çetin GY, Kılıç L, Küçükşahin O, Omma A, Ozisler C, Solmaz D, Bozkirli ED, Akyol L, Pehlevan SM, Gunal EK, Arslan F, Yılmazer B, Atakan N, Aydın SZ; Psoriatic Arthritis Registry of Turkey Study Group. Kalyoncu U, et al. Among authors: omma a. Rheumatology (Oxford). 2017 Feb;56(2):279-286. doi: 10.1093/rheumatology/kew375. Epub 2016 Oct 29. Rheumatology (Oxford). 2017. PMID: 27794533
Decreased Chitotriosidase Activity and Levels in Familial Mediterranean Fever.
Doğan HO, Omma A, Turhan T, Boğdaycıoğlu N, Karaaslan Y, Yavuz H, Demirpençe Ö, Aydın H, Bakır S. Doğan HO, et al. Among authors: omma a. J Korean Med Sci. 2016 Dec;31(12):1902-1906. doi: 10.3346/jkms.2016.31.12.1902. J Korean Med Sci. 2016. PMID: 27822927 Free PMC article.
Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients.
Akar S, Cetin P, Kalyoncu U, Karadag O, Sari I, Cınar M, Yilmaz S, Onat AM, Kisacik B, Erden A, Balkarli A, Kucuksahin O, Oner SY, Senel S, Tufan A, Direskeneli H, Oksuz F, Pehlivan Y, Bayindir O, Keser G, Aksu K, Omma A, Kasifoglu T, Unal AU, Yildiz F, Balci MA, Yavuz S, Erten S, Ozgen M, Sayarlıoglu M, Dogru A, Yildirim G, Oner FA, Tezcan ME, Pamuk ON, Onen F. Akar S, et al. Among authors: omma a. Arthritis Care Res (Hoboken). 2018 Jul;70(7):1090-1094. doi: 10.1002/acr.23446. Epub 2018 Apr 24. Arthritis Care Res (Hoboken). 2018. PMID: 28992387
117 results